Using modeling to inform international guidelines for antiretroviral treatment.
aDepartment of Infectious Disease Epidemiology, Imperial College London, London, UK bCenter for Health Decision Science, Harvard School of Public Health, Boston, Massachusetts, USA cCentre for Health Economics, University of York, York, UK dSouth African Department of Science and Technology/National Research Foundation Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa eDepartment of Epidemiology, University of California, Los Angeles, CA, USA.
Timothy B
TB
Hallett
Nicolas A
NA
Menzies
Paul
P
Revill
Daniel
D
Keebler
Annick
A
Bórquez
Ellen
E
McRobie
Jeffrey W
JW
Eaton
D006801:Humans; D044966:Anti-Retroviral Agents / Q000191:economics / Q000627:therapeutic use; D014943:Global Health; D006291:Health Policy; D015658:HIV Infections / Q000188:drug therapy; D015233:Models, Statistical; D017410:Practice Guidelines as Topic
D044966:Anti-Retroviral Agents